Dri Healthcare TrustOTC Pink - Current Information:DHTRFView on Canadian Exchange
- LAST PRICE9.0800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots6.8000/ 1
- Ask / Lots13.0200/ 1
- Open / Previous Close9.0800 / 9.0800
- Day Range
- 52 Week Range
- Volume2,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | DHTRF |
|---|
Industry Peers
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Dri Healthcare Trust | --- | --- | --- |
Company Information
DRI Healthcare Trust is a Canada-based company engaged in providing financing to advance innovation in the life sciences industry. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires approximately 70 royalties on 45-plus drugs, including Eylea, Spinraza, Zytiga, Remicade, Keytruda, Stelara, and Xenpozyme. Its portfolio includes Empaveli, Eylea, Natpara, Omidria, Rydapt, Simponi, Syfovre, Vonjo, Zejula and Zytiga. Its therapeutic areas include influenza, endocrinology, ophthalmology, dermatology, oncology, neurology, autoimmune diseases, heme-onc, lysosomal storage disorder, respiratory diseases, oncology and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; Novartis; Biogen; CTI Biopharma; Roche, Novartis, Johnson & Johnson, Sanofi S.A., and others.
Contact Information
- Headquarters
- 1 First Canadian Place Suite 7250, 100 King Street WestToronto, ON, Canada M5X 1B1
- Phone
- 416-863-1865
- Fax
- ---
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | --- |
|---|---|
Revenue (TTM) | --- |
Shares Outstanding | --- |
Dividend Yield | 3.74% |
Annual Dividend Rate | 0.3400 USD |
Ex-Dividend Date | 09-30-24 |
Pay Date | 10-18-24 |
Beta | --- |
EPS | --- |
Book Value | --- |
P/E Ratio | --- |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
